Serological Thymidine Kinase 1 is a Biomarker for Early Detection of Tumours—A Health Screening Study on 35,365 People, Using a Sensitive Chemiluminescent Dot Blot Assay

Serological Thymidine Kinase 1 is a Biomarker for Early Detection of Tumours—A Health Screening Study on 35,365 People, Using a Sensitive Chemiluminescent Dot Blot Assay

Serological thymidine kinase 1 (STK1) is a reliable proliferation marker for prognosis, monitoring tumour therapy, and relapse. Here we investigated the use of STK1 in health screening for early detection of pre-malignant and malignant diseases. The investigation was based on 35,365 participants in...

Full description

Bibliographic Details
Main Authors: Ellen He, Ying Hong Wang, Qu Bo Chen, Yan Chen, Jian Wen, Xiao Hong Xu, Yande Wang, Ai Zhen Yang, Shou Qing Huang, Zhi Heng Chen, Ji Zhou, Sven Skog
Format: Article
Language:English
Published: MDPI AG 2011-11-01
Series:Sensors
Subjects:
thymidine kinase 1
health screening
pre-malignancy
malignancy
biomarker
tumour marker
Online Access:http://www.mdpi.com/1424-8220/11/12/11064/

Internet

http://www.mdpi.com/1424-8220/11/12/11064/

Similar Items